They were very clear yesterday that any expansion of the estimated revenue above that number hurts our credibility.
"It's too good to be true" is a powerful force in the minds of investors; so we'll have to be satisfied with the super conservative, low estimate of $7Bn in one category.
In response to a nonsense argument yesterday from our friend staying from out of town where Nuts said: how can you be $7Bn in a $1.5Bn category?
The answer can point to Keytruda which does nothing nearly as high as 40% responses, and is now selling over $20Bn per annum, in a category that was zero in 2012.
They were very clear yesterday that any expansion of the...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.050(3.03%) |
Mkt cap ! $289.6M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.70 | $1.63 | $181.9K | 109.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11946 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 27579 | 4 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |